Trial · NCT01450761
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomization | STARTED | Ipilimumab and Platinum/Etoposide | 566 | |
| Randomization | STARTED | Placebo and Platinum/Etoposide | 566 | |
| Randomization | COMPLETED | Ipilimumab and Platinum/Etoposide | 562 | |
| Randomization | COMPLETED | Placebo and Platinum/Etoposide | 561 | |
| Randomization | NOT COMPLETED | Ipilimumab and Platinum/Etoposide | 4 | |
| Randomization | NOT COMPLETED | Placebo and Platinum/Etoposide | 5 | |
| Lead-in Chemotherapy | STARTED | Ipilimumab and Platinum/Etoposide | 562 | |
| Lead-in Chemotherapy | STARTED | Placebo and Platinum/Etoposide | 561 | |
| Lead-in Chemotherapy | COMPLETED | Ipilimumab and Platinum/Etoposide | 478 | |
| Lead-in Chemotherapy | COMPLETED | Placebo and Platinum/Etoposide | 476 | |
| Lead-in Chemotherapy | NOT COMPLETED | Ipilimumab and Platinum/Etoposide | 84 | |
| Lead-in Chemotherapy | NOT COMPLETED | Placebo and Platinum/Etoposide | 85 | |
| Treatment With Blinded Study Therapy | STARTED | Ipilimumab and Platinum/Etoposide | 478 | |
| Treatment With Blinded Study Therapy | STARTED | Placebo and Platinum/Etoposide | 476 | |
| Treatment With Blinded Study Therapy | COMPLETED | Ipilimumab and Platinum/Etoposide | 0 | |
| Treatment With Blinded Study Therapy | COMPLETED | Placebo and Platinum/Etoposide | 0 | |
| Treatment With Blinded Study Therapy | NOT COMPLETED | Ipilimumab and Platinum/Etoposide | 478 | |
| Treatment With Blinded Study Therapy | NOT COMPLETED | Placebo and Platinum/Etoposide | 476 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01450761/flow